Glooko

Glooko operates a connected care platform focused exclusively on diabetes management, serving both healthcare providers and people living with diabetes. The platform consolidates data from over 200 diabetes monitoring devices, including continuous glucose monitors, insulin pumps, blood glucose meters, and connected insulin pens. With 4.4 million patients who have used the platform globally, Glooko provides remote patient monitoring capabilities across clinics in multiple countries.

The company's platform integrates with electronic health record systems, including direct Epic access, and offers specialized solutions for different markets. Glooko XT serves as their remote patient monitoring solution tailored specifically for the French healthcare landscape and regulatory requirements. Healthcare providers use the platform to visualize patient data across multiple timeframes, streamline clinical workflows, and reduce administrative burden associated with diabetes data management.

Glooko maintains partnerships with major diabetes device manufacturers and pharmaceutical companies, including Abbott, Dexcom, Novo Nordisk, and Tandem Diabetes. The platform holds ISO 27001 certification for information security management and complies with GDPR requirements. Data storage locations vary by region, with German and French data stored in Frankfurt and other EU data stored in Dublin.

Healthcare organizations should consider Glooko when they need a proven, specialized platform for diabetes population management with extensive device compatibility. The platform excels in environments where patients use diverse monitoring devices and where remote care delivery is a priority.

Organizations can expect a centralized data management system that reduces the time clinicians spend on data aggregation and enables more efficient virtual consultations. The free patient mobile application removes cost barriers to patient adoption, while the extensive device ecosystem minimizes friction in data collection from existing patient-owned devices.

Glooko serves exclusively healthcare organizations and patients in the diabetes care vertical. The platform addresses specific diabetes management workflows including insulin titration, continuous glucose monitoring interpretation, and multi-device data reconciliation. The company maintains medical device registration as a Class IIa device under EU Medical Device Regulation and provides region-specific solutions like Glooko XT for French healthcare providers.

Healthcare provider customers include university medical centers, regional health systems, and specialized diabetes clinics. The platform supports team-based diabetes care models with features designed for endocrinologists, certified diabetes educators, and primary care physicians managing diabetes populations.

Ideal clients are large health systems, hospital networks, or specialized diabetes clinics managing hundreds or thousands of patients with diabetes who use various monitoring devices. Organizations with established Epic EHR systems and those pursuing value-based care models for diabetes populations will benefit most from the platform's capabilities. European healthcare providers requiring GDPR-compliant solutions with region-specific data storage will find the platform well-aligned with regulatory requirements.